http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102656142-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_132aa5ddba376cda52c2bedb26765245
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C2601-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C2601-02
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C311-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C311-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C307-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C311-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C311-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C307-10
filingDate 2010-10-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a820fa4cb711e76fd2e56f5a244934c4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_058c7378fa240f6ba3c9eb6e207e160b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d6481a6d084cb1506937f1da3b351705
publicationDate 2012-09-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-102656142-A
titleOfInvention Substituted benzenesulfonamides
abstract The present invention relates to the substituted benzenesulfonamide compound shown in general formula (I): (I) wherein R1, R2, R3, R4, R5 and A are as defined in the claims, processes for preparing said compounds, pharmaceutical compositions and combinations comprising said compounds, and said compounds as individual active agents or Use together with other active ingredients in the preparation of a pharmaceutical composition for the treatment or prevention of diseases, especially hyperproliferative and/or angiogenic disorders.
priorityDate 2009-10-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-3867437-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008138639-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466351355
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466465692
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466071580
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415786576
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467413609
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID89185

Total number of triples: 34.